Senior unsecured convertible bonds by Alvotech S.A– USD 108 million

DNB Carnegie acted as Sole Bookrunner for Alvotech’s USD 108 million senior unsecured convertible bonds by Alvotech. Alvotech is a global biopharma company focused on the development, manufacturing and commercialization of biosimilars.